Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasis.
blood brain barrier
cancer
dkk-1
metabolites
metastasis
microenvironment
microfluidic
secretions
secretome
Journal
Advanced nanobiomed research
ISSN: 2699-9307
Titre abrégé: Adv Nanobiomed Res
Pays: Germany
ID NLM: 101773117
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
pmc-release:
01
04
2024
medline:
26
5
2023
pubmed:
26
5
2023
entrez:
26
5
2023
Statut:
ppublish
Résumé
Brain metastases are the most lethal progression event, in part because the biological processes underpinning brain metastases are poorly understood. There is a paucity of realistic models of metastasis, as current
Identifiants
pubmed: 37234365
doi: 10.1002/anbr.202200036
pmc: PMC10208594
mid: NIHMS1872784
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R33 CA261696
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA046592
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI116482
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009676
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA245597
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA196018
Pays : United States
Références
Nat Rev Clin Oncol. 2021 Nov;18(11):696-714
pubmed: 34253912
Front Oncol. 2017 Dec 11;7:298
pubmed: 29312881
Sci Rep. 2015 May 18;5:9980
pubmed: 25984707
Front Cell Neurosci. 2018 Aug 03;12:235
pubmed: 30123112
Brain Sci. 2021 Apr 07;11(4):
pubmed: 33917013
Mol Med. 2016 Sep;22:32-40
pubmed: 26837070
Front Cell Neurosci. 2018 Nov 12;12:414
pubmed: 30483064
Cancer Genomics Proteomics. 2015 Jul-Aug;12(4):167-77
pubmed: 26136217
Front Cell Neurosci. 2013 Apr 16;7:40
pubmed: 23596394
Front Biosci (Landmark Ed). 2017 Jun 1;22(10):1805-1829
pubmed: 28410147
Mol Cell Proteomics. 2015 Sep;14(9):2316-30
pubmed: 26041846
Nat Med. 2018 Jul;24(7):1024-1035
pubmed: 29892069
Sci Rep. 2018 May 29;8(1):8267
pubmed: 29844613
Neuro Oncol. 2017 Oct 19;19(11):1511-1521
pubmed: 28444227
J Neuroinflammation. 2016 Sep 10;13(1):242
pubmed: 27612942
Am J Pathol. 2010 Jun;176(6):2958-71
pubmed: 20382702
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Carcinogenesis. 2011 Mar;32(3):434-42
pubmed: 21173432
Rev Neurosci. 2018 Jul 26;29(5):567-591
pubmed: 29306934
J Immunother Cancer. 2019 Nov 8;7(1):293
pubmed: 31703602
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
J Vis Exp. 2020 Aug 16;(162):
pubmed: 32865534
Nat Rev Cancer. 2021 Oct;21(10):669-680
pubmed: 34272515
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Anticancer Res. 2016 Nov;36(11):5639-5647
pubmed: 27793885
Biomed Pharmacother. 2020 Jun;126:110086
pubmed: 32172060
Mol Cancer Ther. 2004 Dec;3(12):1585-92
pubmed: 15634652
J Thorac Dis. 2016 Nov;8(11):E1450-E1454
pubmed: 28066629
Immunity. 2017 Jun 20;46(6):957-967
pubmed: 28636962
BMC Cancer. 2018 Apr 19;18(1):446
pubmed: 29673325
Sci Rep. 2016 Dec 19;6:39190
pubmed: 27991524
Am J Cancer Res. 2017 Sep 01;7(9):1754-1768
pubmed: 28979801
Nat Commun. 2018 Jul 13;9(1):2705
pubmed: 30006619
Front Immunol. 2019 Jun 11;10:1314
pubmed: 31244853
Front Immunol. 2019 Aug 20;10:1941
pubmed: 31481958
Lab Chip. 2019 Mar 27;19(7):1162-1173
pubmed: 30810557
Cancer Res. 2017 Dec 1;77(23):6692-6703
pubmed: 28986380
Nat Commun. 2019 Jun 11;10(1):2541
pubmed: 31186414
Cell. 2014 Feb 27;156(5):1002-16
pubmed: 24581498